GHRP-6: the first generation powerhouse GHRP-6 was the first synthetic GHRP developed for GH-releasing activity
As each metabolite varies slightly in structure, receptor binding ability or affinities may differ (Ujvry and Hanu 2016)
Choosing between them on evidence alone is difficult because robust head-to-head human trials do not exist
Where should I keep my HCG vials
Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results
Gastrointestinal Protection BPC-157 has shown protective and healing effects on the GI tract in numerous models, including NSAID-induced ulcers, inflammatory bowel disease models, and alcohol-induced damage
